$ACU

ACME UNITED CORP

CIK:0000002098|SEC Filings

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 62,716	$ 53,996	$ 115,017	$ 99,954
Cost of goods sold	36,028	31,847	67,544	59,888
Gross profit	26,688	22,149	47,473	40,066
Selling, general and administrative expenses	19,858	15,759	38,899	31,250
Operating income	6,830	6,390	8,574	8,816
Non-operating items:
Interest expense, net	532	401	1,018	798
Other (income) expense, net	(5)	(99)	11	(188)
Income before income tax expense	6,303	6,088	7,545	8,206
Income tax expense	1,252	1,336	1,511	1,802
Net income	$ 5,051	$ 4,752	$ 6,034	$ 6,404
Basic earnings per share	$ 1.32	$ 1.26	$ 1.58	$ 1.7
Diluted earnings per share	$ 1.22	$ 1.16	$ 1.46	$ 1.57
Weighted average number of common shares outstanding-denominator used for basic per share computations	3,820,000	3,785,000	3,815,000	3,772,000
Weighted average number of dilutive stock options outstanding	321,000	319,000	323,000	298,000
Denominator used for diluted per share computations	4,141,000	4,104,000	4,138,000	4,070,000
Dividends declared per share	$ 0.16	$ 0.16	$ 0.32	$ 0.31

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income	$ 6,034	$ 6,404
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	2,297	1,766
Amortization of intangible assets	1,621	1,258
Non-cash lease adjustment	56	(10)
Stock compensation expense	689	787
Provision for credit losses	60	12
Provision for excess and obsolete inventory	0	140
Amortization of deferred financing costs	30	20
Changes in operating assets and liabilities:
Accounts receivable	(9,349)	(7,764)
Inventories	(1,911)	(362)
Prepaid expenses and other assets	(592)	370
Accounts payable	5,668	1,056
Other accrued liabilities	6,284	(679)
Total adjustments	4,853	(3,406)
Net cash provided by operating activities	10,887	2,998
Cash flows from investing activities:
Purchase of property, plant and equipment	(2,957)	(2,973)
Acquisition of My Medic	(14,412)	0
Net cash used in investing activities	(17,369)	(2,973)
Cash flows from financing activities:
Net borrowings of long-term debt	10,766	(1,266)
Tax withholding on net share settlement of stock options	(395)	(355)
Cash settlement of stock options	(1,462)	(568)
Repayments on mortgage	(205)	(205)
Proceeds from issuance of common stock	464	602
Distributions to shareholders	(1,219)	(1,171)
Net cash provided by financing activities	7,949	(2,963)
Effect of exchange rate changes on cash and cash equivalents	(22)	180
Net change in cash and cash equivalents	1,445	(2,758)
Cash and cash equivalents at beginning of period	3,596	6,399
Cash and cash equivalents at end of period	5,041	3,641
Supplemental cash flow information:
Cash paid for income taxes	125	206
Cash paid for interest	$ 928	$ 778

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 5,041	$ 3,596
Accounts receivable, less allowance for credit losses of $564 in 2026 and $494 in 2025	38,726	29,098
Inventories	64,099	59,852
Prepaid expenses and other current assets	4,465	3,649
Total current assets	112,331	96,195
Property, plant and equipment:
Land	3,486	3,487
Buildings	24,436	24,051
Machinery and equipment	45,966	43,462
Total property, plant and equipment	73,888	71,000
Less: accumulated depreciation	34,671	32,459
Net property, plant and equipment	39,217	38,541
Operating lease right-of-use asset, net	6,001	6,881
Goodwill	9,908	9,908
Intangible assets, less accumulated amortization	33,188	19,473
Total assets	200,645	170,998
Current liabilities:
Accounts payable	14,151	8,065
Operating lease liability - current portion	1,330	1,446
Current portion of mortgage payable	463	454
Other current liabilities	18,870	12,906
Total current liabilities	34,814	22,871
Long-term debt	22,637	11,853
Mortgage payable, net of current portion	9,229	9,432
Operating lease liability - non-current portion	4,821	5,532
Deferred income taxes	3,685	3,685
Other non-current liabilities	4,157	14
Total liabilities	79,343	53,387
Commitments and contingencies (see note 2)
STOCKHOLDERS' EQUITY
Common stock, par value $2.50: authorized 8,000,000 shares; 5,378,695 shares issued and 3,833,823 shares outstanding in 2026 and 5,351,596 shares issued and 3,806,724 shares outstanding in 2025	13,447	13,379
Additional paid-in capital	18,734	19,506
Retained earnings	107,103	102,293
Treasury stock, at cost - 1,544,872 shares in 2026 and 2025	(15,996)	(15,996)
Accumulated other comprehensive loss:
Translation adjustment	(1,986)	(1,571)
Total stockholders’ equity	121,302	117,611
Total liabilities and stockholders’ equity	$ 200,645	$ 170,998